Carregant...
Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
BACKGROUND: Ezetimibe (Zetia(®)) is a potent inhibitor of cholesterol absorption that has been approved for the treatment of hypercholesterolemia. Statin, an inhibitor of cholesterol synthesis, is the first-choice drug to reduce low-density lipoprotein-cholesterol (LDL-C) for patients with hyperchol...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2009
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2768708/ https://ncbi.nlm.nih.gov/pubmed/19821987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-8-41 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|